John Turnidge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
John Turnidge has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Jan M. Bell
Women's and Children's Hospital Adelaide Australia
3 shared publications Douglas E Kepner
Focus Technologies Inc, Virginia, United States of America
2 shared publicationsJ. Bell
2 shared publicationsM.J. Dowzicky
2 shared publications- Peter Collignon
Medical School, Australian National University, Canberra 2601, Australia
2 shared publications R. Jones
2 shared publications
Latest Publications
- 1 December 2008
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 12, e411-e412
Antimicrobial Activity of Tigecycline Tested against Contemporary Bacterial Isolates Collected in Australia (2006)
- 1 December 2008
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 12, e411-e412
Antimicrobial Activity of Tigecycline Tested against Contemporary Bacterial Isolates Collected in Australia (2006)
- 1 May 2006
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 12 (5) , 418-425
Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values
- 1 May 2006
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 12 (5) , 418-425
Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values
- 1 February 2005
- Published by Elsevier in The Lancet
- Vol. 365 (9459) , 548-549
Antibiotic use and resistance—proving the obvious
- 1 February 2005
- Published by Elsevier in The Lancet
- Vol. 365 (9459) , 548-549
Antibiotic use and resistance—proving the obvious
- Open Access
- 24 March 2004
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 53 (5) , 886
Reply
*Tel: +61-8-8204-8873; Fax: +61-8-8204-6051; E-mail: turnidgej@wch.sa.gov.au
- 24 March 2004
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 53 (5) , 886
Open AccessReply
*Tel: +61-8-8204-8873; Fax: +61-8-8204-6051; E-mail: turnidgej@wch.sa.gov.au
- Open Access
- 4 December 2003
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 53 (1) , 26-27
Antibiotic use in animals--prejudices, perceptions and realities
Regulatory authorities have suspended the use of some antibiotics as growth promoters in animal feed. The subject remains a hotly debated topic around the world. Controversy surrounds whether such use in animals presents a real risk of increasing resistance in human pathogens, and hence a human health problem. Views tend to be polarized. Proponents of the bans point to falling rates of resistance in animal and human isolates as a direct result; detractors question whether evidence exists for a link between growth promoter use and resistance in human pathogens and cite a decline in animal health among the undesirable effects. The article by Phillips et al. in this issue puts one view, this article aims to consider the merits of the arguments put forward by both sides and looks to a way forward.
- 4 December 2003
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 53 (1) , 26-27
Open AccessAntibiotic use in animals--prejudices, perceptions and realities
Regulatory authorities have suspended the use of some antibiotics as growth promoters in animal feed. The subject remains a hotly debated topic around the world. Controversy surrounds whether such use in animals presents a real risk of increasing resistance in human pathogens, and hence a human health problem. Views tend to be polarized. Proponents of the bans point to falling rates of resistance in animal and human isolates as a direct result; detractors question whether evidence exists for a link between growth promoter use and resistance in human pathogens and cite a decline in animal health among the undesirable effects. The article by Phillips et al. in this issue puts one view, this article aims to consider the merits of the arguments put forward by both sides and looks to a way forward.
- 1 September 2003
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 17 (3) , 503-528
Pharmacodynamics and dosing of aminoglycosides
- 1 September 2003
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 17 (3) , 503-528
Pharmacodynamics and dosing of aminoglycosides
- Open Access
- 30 May 2003
- Published by Australian Centre for Disease Control in Communicable Diseases Intelligence
- Vol. 27, S67-S69
TSN® Database Australia, a new tool to monitor antimicrobial resistance in Australia
An electronic network of Australian microbiology laboratories was established to monitor the emergence and occurrence of antimicrobial resistance among clinically relevant bacteria. It is believed that the data network collected approximately 42 per cent of all antibacterial susceptibility test results generated by Australian laboratories. The network comprised 94 hospitals and 9 private commercial laboratories. Selected data elements were extracted and electronically transmitted to a central location. Upon receipt, all data were first normalised and thereafter examined for errors. Duplicate results for the same patient were identified to prevent skewing of the data toward resistance. All data passing quality assessment was staged for release of a new database release that occurred monthly. Unusual test results were first validated prior to their inclusion into the database. Using an Internet-based query tool, individual institutions could query their own data, but could only query aggregated data for other regional or national analyses. Individual patient results could be examined nor could the results of any individual institution other than their own. As of March 2002, TSN Database Australia contained 14,648,752 test results, from 2,000,394 strains (453 different taxa) and 1,213,605 patients. Since the same database concept has been established in 10 other countries (United States of America, Europe, and Canada), observations made in Australia may be compared to those observed elsewhere in the world. This article will describe TSN in greater detail, describe the query tool and some of the analyses that are possible. Commun Dis Intell 2003;27 Suppl:S67-S69.
- 30 May 2003
- Published by Australian Centre for Disease Control in Communicable Diseases Intelligence
- Vol. 27, S67-S69
Open AccessTSN® Database Australia, a new tool to monitor antimicrobial resistance in Australia
An electronic network of Australian microbiology laboratories was established to monitor the emergence and occurrence of antimicrobial resistance among clinically relevant bacteria. It is believed that the data network collected approximately 42 per cent of all antibacterial susceptibility test results generated by Australian laboratories. The network comprised 94 hospitals and 9 private commercial laboratories. Selected data elements were extracted and electronically transmitted to a central location. Upon receipt, all data were first normalised and thereafter examined for errors. Duplicate results for the same patient were identified to prevent skewing of the data toward resistance. All data passing quality assessment was staged for release of a new database release that occurred monthly. Unusual test results were first validated prior to their inclusion into the database. Using an Internet-based query tool, individual institutions could query their own data, but could only query aggregated data for other regional or national analyses. Individual patient results could be examined nor could the results of any individual institution other than their own. As of March 2002, TSN Database Australia contained 14,648,752 test results, from 2,000,394 strains (453 different taxa) and 1,213,605 patients. Since the same database concept has been established in 10 other countries (United States of America, Europe, and Canada), observations made in Australia may be compared to those observed elsewhere in the world. This article will describe TSN in greater detail, describe the query tool and some of the analyses that are possible. Commun Dis Intell 2003;27 Suppl:S67-S69.